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How do we decide when a patient
with nonmalignant disease 
is eligible for hospice care?
❚ Evidence summary
Hospices have varying admission criteria.
However, according to US law, patients must
be certified to be “terminally ill” with a prog-
nosis of less than 6 months to live in order to
qualify for the Medicare hospice benefit.1 US
law and Medicare regulations specify that an
attending physician and the accepting 
hospice medical director must agree to the
prognosis for certification of eligibility.
Brickner et al’s survey2 demonstrated
that physicians find accurate prognostica-
tion difficult. Furthermore, many of the
common noncancer diseases have erratic
and unpredictable courses, making prog-
nosis even harder. Indeed, patients with
noncancer diagnoses are typically admitted
to hospices later in their terminal course,3
resulting in increased inpatient hospital
stays4 and ultimately lower patient and
Each hospice has its own policy, but
Medicare requires 6 months or less life
expectancy for certification of eligibility and
reimbursement. Other important criteria
include patient and family understanding
and wishes.
Evidence-based guidelines for 
determining prognosis in some noncancer
diseases have been developed. However,
despite their widespread use, limited data
exist to support their accuracy (strength 
of recommendation: B). Moreover, a high
degree of prognostic accuracy may be
unattainable given the unpredictable 
course of common noncancer chronic 
diseases. Hospice eligibility for patients 
with nonmalignant disease is based on 
clinical judgment.
Refer to hospice when goals are focused
on quality of life rather than intervention
Hospice referral with a nonmalignant 
diagnosis is challenging but essential to
quality patient care. Between episodes of
disease exacerbations, we need to take an
active role in discussing goals of care,
remembering that some patients and 
families need “permission” to change to 
palliative goals rather than continuing with
aggressive interventions. My gauge of when
to refer to hospice is when the goals of care
become focused on quality of life and 
staying out of the hospital rather than 
intervention in the disease course. Most
patients underuse the benefits that a 
hospice referral can provide, and while 
some patients outlive the 6-month criteria
for hospice care, this benefit can be
renewed if the patient still meets the criteria.
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family satisfaction.5 The difficulties inher-
ent in prognostication were underscored
by a study that found patients with non-
cancer diagnoses to be much more likely to
be discharged from hospice alive.6
The National Hospice Organization
(NHO) has created guidelines7 for deter-
mining prognosis in selected noncancer
diseases including heart disease, pul-
monary disease, dementia, HIV, liver 
disease, renal disease, stroke, coma, and
amyotrophic lateral sclerosis (ALS). To
validate these guidelines, one group identi-
fied 2607 patients who meet the NHO
guidelines.8 Only 655 (25%) were dead
within 6 months. The estimated median
survival of these identified patients was
804 days. When every potential prognostic
criterion was met (far more than NHO
standards) only 19 of the 2607 patients
qualified for hospice, and yet 10 of them
were still alive at 6 months. Unlike many
cancers, in which there is a steady terminal
decline, diseases such as chronic obstruc-
tive pulmonary disease, congestive heart
failure, and liver failure are characterized
by a baseline of moderate functioning 
with intermittent—often life-threatening—
exacerbations. 
A recent Clinical Inquiry9 addressed
the issue of hospice care for patients with
late-stage Alzheimer’s disease. That evi-
dence-based answer concluded that criteria
superior to the NHO guidelines or clinical
judgment had been established for progno-
sis of Alzheimer’s disease. However, using
those improved criteria yielded only mar-
ginally more accurate prognostication. At
best, 71% of the patients predicted to live
less than 6 months did so, but only if the
patients had progressed through the dis-
ease in an orderly fashion. For the larger
subset of patients, those who did not
progress through Alzheimer’s in a pre-
dictable way, only 30% of the patients
actually died within 6 months.
Recommendations from others
The NHO7 provides parameters to help
determine a 6-month life expectancy. The
“General Guidelines for Determining
Prognosis” are summarized in the TABLE.
Further details of the “general guidelines”
as well as guidelines for prognosis in spe-
cific diseases (heart disease, pulmonary dis-
ease, dementia, HIV, liver disease, renal
disease, stroke, coma, and ALS) are out-
lined by the NHO.7
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Many noncancer
diseases have
erratic courses;
patients enter 
hospices later in
their course, with
longer stays and
lower patient 
satisfaction
FAST TRACK
TA B L E
Patients should meet all of the following criteria:
I. The patient’s condition is life limiting, and the patient and/or family have
been informed of this determination.
II. The patient and/or family have elected treatment goals directed toward
relief of symptoms, rather than cure of the underlying disease.
III. The patient has either of the following:
A. Documented clinical progression of disease.
B. Documented recent impaired nutritional status related to the terminal
process.
Hospice criteria
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